Delivery Order SPE2DP20D0002-SPE2DP21F3779
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Adenovirus Type 4 vaccine to Parsippany, New Jersey. The prime contractor is Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract has a firm fixed price of $423,530.64 and a completion date of November 16, 2021. This delivery order is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. has previously...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The firm-fixed-price contract has a potential value of $141,176.88 and an August 24, 2021 completion date. The place of performance is Parsippany, New Jersey. No set-aside designation is noted. Teva Pharmaceuticals USA, Inc. has provided various drug products, including vaccines,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of adenovirus type 4 vaccine. The contract has a firm fixed price of $271,494.00 and a completion date of December 15, 2020. The place of performance is Parsippany, New Jersey. There is no set-aside designation indicated. Teva Pharmaceuticals USA, Inc. has a history of providing various drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of adenovirus type 4 vaccine. The contract is a firm fixed-price delivery order with a potential value of $282,353.76 and a completion date of June 22, 2021. The place of performance is Parsippany, New Jersey. This contract does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit...
- This delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a firm fixed-price (FFP) pricing type and a potential value of $282,353.76. The place of performance is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antiviral...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 award is to provide Adenovirus Type 4 vaccine, with an ultimate completion date of March 26, 2024. Teva Pharmaceuticals USA is an experienced federal contractor, having been awarded numerous prime contracts and delivery orders by agencies such as the Department of Veterans...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The $271,494.00 firm fixed-price contract has a completion date of July 28, 2020. This award is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. has previously provided various pharmaceutical products, including vaccines, antiviral medications,...
- This is a delivery order award to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency Troop Support Medical. The $146,823.93 firm-fixed-price contract is for the delivery of adenovirus type 4 vaccines to be performed in Parsippany, New Jersey by August 30, 2022. Teva is an experienced provider of pharmaceutical products to federal agencies, having received numerous awards from the Defense Logistics Agency and Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract is a firm-fixed-price delivery order with a potential value of $271,494.00 and a completion date of December 15, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products, including vaccines, antiviral...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The firm-fixed-price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. The award was made on November 3, 2020, and there was no set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP21F3779Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of adenovirus type 4 vaccine. The $141,176.88 firm fixed-price contract has a completion date of May 25, 2021 and was awarded on May 6, 2021. The place of performance is Parsippany, New Jersey. This delivery order was not set aside for any socioeconomic categories. Teva Pharmaceuticals USA, Inc. has provided various pharmaceutical products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis drugs, to federal customers such as the Department of Defense and Department of Veterans Affairs through both delivery orders and indefinite delivery/indefinite quantity (IDIQ) contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $141.2k | 5/6/21 |